Health Pulse 28 Sep 2026 STAT+: Merck discontinues a crucial antibiotic despite concerns over superbug resistance In an unexpected move, Merck discontinued an important antibiotic from the U.S. market earlier this month, underscoring…
Health Pulse 28 Sep 2026 STAT+: AbbVie wins FDA nod for Parkinson’s pill Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your…
Health Pulse 28 Sep 2026 STAT+: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating…
Health Pulse 28 Sep 2026 STAT+: Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’ Blockbuster GLP-1 drugs have transformed the lives of millions of people. Lately, they’re undergoing a makeover of…
Health Pulse 28 Sep 2026 Opinion: AI is eroding the barriers that kept biological weapons rare Earlier this month, Anthropic reported five cases in which people used its models for work that could support…
Health Pulse 26 Sep 2026 Opinion: I worked on the CDC investigation of the anthrax letters. 25 years later, are we ready for the next biothreat? Twenty-five years ago, as the country still reeled from Sept. 11, the first of two batches of anthrax-laden envelopes…
Health Pulse 25 Sep 2026 STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals with 11 manufacturers to…